The role of dendritic cells in immune responses against vaginal infection by herpes simplex virus type 2

Microbes and Infection

Volumn 5, Issue 13, 2003, Pages 1221-1230

  Iwasaki, Akiko ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genitalia, female; Lymph nodes; Mucosal immunity; Sexually transmitted diseases, viral; Th1 cells

Indexed keywords

CELLULAR IMMUNITY; DENDRITIC CELL; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNE RESPONSE; IMMUNITY; MENSTRUAL CYCLE; PRIORITY JOURNAL; REVIEW; TARGET CELL; VAGINA MUCOSA; VAGINITIS; VIRUS TRANSMISSION;

HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

EID: 0242569480     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2003.09.006     Document Type: Short Survey

References (82)

1. Fleming D.T., McQuillan G.M., Johnson R.E., Nahmias A.J., Aral S.O., Lee F.K., St Louis M.E. Herpes simplex virus type 2 in the United States, 1976-1994. N. Engl. J. Med. 337:1997;1105-1111.
2. Cameron D.W., Simonsen J.N., D'Costa L.J., Ronald A.R., Maitha G.M., Gakinya M.N., Cheang M., Ndinya-Achola J.O., Piot P., Brunham R.C., et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet. 2:1989;403-407.
3. Stamm W.E., Handsfield H.H., Rompalo A.M., Ashley R.L., Roberts P.L., Corey L. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA. 260:1988;1429-1433.
4. Parr M.B., Parr E.L. Protective immunity against HSV-2 in the mouse vagina. J. Reprod. Immunol. 36:1997;77-92.
5. Parr M.B., Kepple L., McDermott M.R., Drew M.D., Bozzola J.J., Parr E.L. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab. Invest. 70:1994;369-380.
6. Tomishima M.J., Smith G.A., Enquist L.W. Sorting and transport of alpha herpesviruses in axons. Traffic. 2:2001;429-436.
7. Shukla D., Spear P.G. Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J. Clin. Invest. 108:2001;503-510.
8. Spear P.G., Eisenberg R.J., Cohen G.H. Three classes of cell surface receptors for alphaherpesvirus entry. Virology. 275:2000;1-8.
9. Herold B.C., Visalli R.J., Susmarski N., Brandt C.R., Spear P.G. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J. Gen. Virol. 75:1994;1211-1222.
10. Shieh M.T., Spear P.G. Herpesvirus-induced cell fusion that is dependent on cell surface heparan sulfate or soluble heparin. J. Virol. 68:1994;1224-1228.
11. Shieh M.T., WuDunn D., Montgomery R.I., Esko J.D., Spear P.G. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol. 116:1992;1273-1281.
12. Spear P.G., Shieh M.T., Herold B.C., WuDunn D., Koshy T.I. Heparan sulfate glycosaminoglycans as primary cell surface receptors for herpes simplex virus. Adv. Exp. Med. Biol. 313:1992;341-353.
13. Herold B.C., WuDunn D., Soltys N., Spear P.G. Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65:1991;1090-1098.
14. Montgomery R.I., Warner M.S., Lum B.J., Spear P.G. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell. 87:1996;427-436.
15. Warner M.S., Geraghty R.J., Martinez W.M., Montgomery R.I., Whitbeck J.C., Xu R., Eisenberg R.J., Cohen G.H., Spear P.G. A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Virology. 246:1998;179-189.
16. Geraghty R.J., Krummenacher C., Cohen G.H., Eisenberg R.J., Spear P.G. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science. 280:1998;1618-1620.
17. Shukla D., Dal Canto M.C., Rowe C.L., Spear P.G. Striking similarity of murine nectin-1alpha to human nectin-1alpha (HveC) in sequence and activity as a glycoprotein D receptor for alphaherpesvirus entry. J. Virol. 74:2000;11773-11781.
18. Zhao X., Deak E., Soderberg K., Linehan M., Spezzano D., Zhu J., Knipe D.M., Iwasaki A. Vaginal submucosal dendritic cells, but not Langerhans' cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 197:2003;153-163.
19. Green E.L. Biology of the Laboratory Mouse. 1989;Dover Publications, New York.
20. Baker D.A., Plotkin S.A. Enhancement of vaginal infection in mice by herpes simplex virus type II with progesterone. Proc. Soc. Exp. Biol. Med. 158:1978;131-134.
21. Gallichan W.S., Rosenthal K.L. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract. Virology. 224:1996;487-497.
22. Overall J.C. Jr, Kern E.R., Schlitzer R.L., Friedman S.B., Glasgow L.A. Genital herpesvirus hominis infection in mice. I. Development of an experimental model. Infect. Immun. 11:1975;476-480.
23. Parr M.B., Parr E.L. Antigen recognition in the female reproductive tract: I. Uptake of intraluminal protein tracers in the mouse vagina. J. Reprod. Immunol. 17:1990;101-114.
24. Kaushic C., Ashkar A.A., Reid L.A., Rosenthal K.L. Progesterone increases susceptibility and decreases immune responses to genital herpes infection. J. Virol. 77:2003;4558-4565.
25. Young W.G., Newcomb G.M., Hosking A.R. The effect of atrophy, hyperplasia, and keratinization accompanying the estrous cycle on Langerhans' cells in mouse vaginal epithelium. Am. J. Anat. 174:1985;173-186.
26. McDermott M.R., Smiley J.R., Leslie P., Brais J., Rudzroga H.E., Bienenstock J. Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. J. Virol. 51:1984;747-753.
27. Coen D.M., Kosz-Vnenchak M., Jacobson J.G., Leib D.A., Bogard C.L., Schaffer P.A., Tyler K.L., Knipe D.M. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc. Natl. Acad. Sci. USA. 86:1989;4736-4740.
28. Harandi A.M., Svennerholm B., Holmgren J., Eriksson K. Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice. J. Gen. Virol. 82:2001;845-853.
29. Parr M.B., Parr E.L. Immunity to vaginal herpes simplex virus-2 infection in B-cell knockout mice. Immunology. 101:2000;126-131.
30. Parr M.B., Harriman G.R., Parr E.L. Immunity to vaginal HSV-2 infection in immunoglobulin A knockout mice. Immunology. 95:1998;208-213.
31. Ochs H.D., Smith C.I. X-linked agammaglobulinemia. A clinical and molecular analysis. Medicine. 75:1996;287-299. (Baltimore).
32. Parr E.L., Parr M.B. Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2. J. Virol. 71:1997;8109-8115.
33. Mikloska Z., Sanna P.P., Cunningham A.L. Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro. J. Virol. 73:1999;5934-5944.
34. Nagashunmugam T., Lubinski J., Wang L., Goldstein L.T., Weeks B.S., Sundaresan P., Kang E.H., Dubin G., Friedman H.M. In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor. J. Virol. 72:1998;5351-5359.
35. Kuklin N.A., Daheshia M., Chun S., Rouse B.T. Role of mucosal immunity in herpes simplex virus infection. J. Immunol. 160:1998;5998-6003.
36. Milligan G.N., Bernstein D.I., Bourne N. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J. Immunol. 160:1998;6093-6100.
37. Posavad C.M., Koelle D.M., Shaughnessy M.F., Corey L. Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses. Proc. Natl. Acad. Sci. USA. 94:1997;10289-10294.
38. Koelle D.M., Posavad C.M., Barnum G.R., Johnson M.L., Frank J.M., Corey L. Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J. Clin. Invest. 101:1998;1500-1508.
39. Khanna K.M., Bonneau R.H., Kinchington P.R., Hendricks R.L. Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity. 18:2003;593-603.
40. Goldsmith K., Chen W., Johnson D.C., Hendricks R.L. Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response. J. Exp. Med. 187:1998;341-348.
41. McDermott M.R., Goldsmith C.H., Rosenthal K.L., Brais L.J. T lymphocytes in genital lymph nodes protect mice from intravaginal infection with herpes simplex virus type 2. J. Infect. Dis. 159:1989;460-466.
42. Milligan G.N., Bernstein D.I. Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology. 229:1997;259-268.
43. Cunningham A.L., Turner R.R., Miller A.C., Para M.F., Merigan T.C. Evolution of recurrent herpes simplex lesions. An immunohistologic study. J. Clin. Invest. 75:1985;226-233.
44. Cunningham A.L., Merigan T.C. gamma interferon production appears to predict time of recurrence of herpes labialis. J. Immunol. 130:1983;2397-2400.
45. Cunningham A.L., Merigan T.C. Leu-3+ T cells produce gamma-interferon in patients with recurrent herpes labialis. J. Immunol. 132:1984;197-202.
46. Torseth J.W., Merigan T.C. Significance of local gamma interferon in recurrent herpes simplex infection. J. Infect. Dis. 153:1986;979-984.
47. Parr M.B., Parr E.L. The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice. Virology. 258:1999;282-294.
48. Croen K.D. Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J. Clin. Invest. 91:1993;2446-2452.
49. Karupiah G., Xie Q.W., Buller R.M., Nathan C., Duarte C., MacMicking J.D. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science. 261:1993;1445-1448.
50. Wong G.H., Goeddel D.V. Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. Nature. 323:1986;819-822.
51. Milligan G.N. Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2. J. Virol. 73:1999;6380-6386.
52. Parr M.B., Parr E.L. Langerhans cells and T lymphocyte subsets in the murine vagina and cervix. Biol. Reprod. 44:1991;491-498.
53. Macatonia S.E., Knight S.C., Edwards A.J., Griffiths S., Fryer P. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J. Exp. Med. 166:1987;1654-1667.
54. Hill S., Edwards A.J., Kimber I., Knight S.C. Systemic migration of dendritic cells during contact sensitization. Immunology. 71:1990;277-281.
55. Knight S.C. Dendritic cells in contact sensitivity. Res. Immunol. 140:1989;907-910. (discussion 918-926).
56. Knight S.C., Roberts M., Macatonia S.E., Edwards A.J. Blocking of acquisition and presentation of antigen by dendritic cells with cyclosporine. Studies with fluorescein isothiocyanate. Transplantation. 46:1988;48S-53S.
57. Macatonia S.E., Edwards A.J., Knight S.C. Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. Immunology. 59:1986;509-514.
58. Borkowski T.A., Letterio J.J., Farr A.G., Udey M.C. A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 184:1996;2417-2422.
59. Borkowski T.A., Nelson A.J., Farr A.G., Udey M.C. Expression of gp40, the murine homologue of human epithelial cell adhesion molecule (Ep-CAM), by murine dendritic cells. Eur. J. Immunol. 26:1996;110-114.
60. Anjuere F., Martin P., Ferrero I., Fraga M.L., del Hoyo G.M., Wright N., Ardavin C. Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes, and skin of the mouse. Blood. 93:1999;590-598.
61. den Haan J.M., Lehar S.M., Bevan M.J. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192:2000;1685-1696.
62. Iyoda T., Shimoyama S., Liu K., Omatsu Y., Akiyama Y., Maeda Y., Takahara K., Steinman R.M., Inaba K. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195:2002;1289-1302.
63. Pooley J.L., Heath W.R., Shortman K. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J. Immunol. 166:2001;5327-5330.
64. Asselin-Paturel C., Boonstra A., Dalod M., Durand I., Yessaad N., Dezutter-Dambuyant C., Vicari A., O'Garra A., Biron C., Briere F., Trinchieri G. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2:2001;1144-1150.
65. Nakano H., Yanagita M., Gunn M.D. CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 194:2001;1171-1178.
66. Lund J., Sato A., Akira S., Medzhitov R., Iwasaki A. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198:2003;1-9.
67. Smith C.M., Belz G.T., Wilson N.S., Villadangos J.A., Shortman K., Carbone F.R., Heath W.R. Cutting edge: conventional CD8alpha(+) dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1. J. Immunol. 170:2003;4437-4440.
68. Mueller S.N., Jones C.M., Smith C.M., Heath W.R., Carbone F.R. Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus. J. Exp. Med. 195:2002;651-656.
69. Norbury C.C., Sigal L.J. Cross priming or direct priming: is that really the question? Curr. Opin. Immunol. 15:2003;82-88.
70. Salio M., Cella M., Suter M., Lanzavecchia A. Inhibition of dendritic cell maturation by herpes simplex virus. Eur. J. Immunol. 29:1999;3245-3253.
71. Mikloska Z., Bosnjak L., Cunningham A.L. Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1. J. Virol. 75:2001;5958-5964.
72. Pollara G., Speidel K., Samady L., Rajpopat M., McGrath Y., Ledermann J., Coffin R.S., Katz D.R., Chain B. Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunity. J. Infect. Dis. 187:2003;165-178.
73. Samady L., Costigliola E., MacCormac L., McGrath Y., Cleverley S., Lilley C.E., Smith J., Latchman D.S., Chain B., Coffin R.S. Deletion of the virion host shutoff protein (vhs) from herpes simplex virus (HSV) relieves the viral block to dendritic cell activation: potential of vhs- HSV vectors for dendritic cell-mediated immunotherapy. J. Virol. 77:2003;3768-3776.
74. Kruse M., Rosorius O., Kratzer F., Stelz G., Kuhnt C., Schuler G., Hauber J., Steinkasserer A. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J. Virol. 74:2000;7127-7136.
75. Shukla D., Rowe C.L., Dong Y., Racaniello V.R., Spear P.G. The murine homolog (Mph) of human herpesvirus entry protein B (HveB) mediates entry of pseudorabies virus but not herpes simplex virus types 1 and 2. J. Virol. 73:1999;4493-4497.
76. Moron G., Rueda P., Casal I., Leclerc C. CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules. J. Exp. Med. 195:2002;1233-1245.
77. Valladeau J., Ravel O., Dezutter-Dambuyant C., Moore K., Kleijmeer M., Liu Y., Duvert-Frances V., Vincent C., Schmitt D., Davoust J., Caux C., Lebecque S., Saeland S. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity. 12:2000;71-81.
78. Valladeau J., Clair-Moninot V., Dezutter-Dambuyant C., Pin J.J., Kissenpfennig A., Mattei M.G., Ait-Yahia S., Bates E.E., Malissen B., Koch F., Fossiez F., Romani N., Lebecque S., Saeland S. Identification of mouse langerin/CD207 in Langerhans cells and some dendritic cells of lymphoid tissues. J. Immunol. 168:2002;782-792.
79. Ruedl C., Koebel P., Bachmann M., Hess M., Karjalainen K. Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes. J. Immunol. 165:2000;4910-4916.
80. Kamath A.T., Henri S., Battye F., Tough D.F., Shortman K. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood. 100:2002;1734-1741.
81. Henri S., Vremec D., Kamath A., Waithman J., Williams S., Benoist C., Burnham K., Saeland S., Handman E., Shortman K. The dendritic cell populations of mouse lymph nodes. J. Immunol. 167:2001;741-748.
82. Salomon B., Cohen J.L., Masurier C., Klatzmann D. Three populations of mouse lymph node dendritic cells with different origins and dynamics. J. Immunol. 160:1998;708-717.